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Background: Large-scale macrophage infiltration and reactive astrogliosis are hallmarks of early spinal cord injury (SCI)
pathology. The exact nature of the macrophage response and relationship between these phenomena have not been
explored in detail. Here, we have investigated these responses using a combination of in vivo SCI models, organotypic
and primary cultures.
Methods: In vivo macrophage response was investigated using a contusive injury mouse model. Interactions between
astrocytes and macrophages were studied in primary or organotypic cultures. Proliferation was assessed though MTT
assay and nucleotide incorporation and gene expression changes through qPCR.
Results: Seven days following contusive SCI, a mixed M1/M2 macrophage response was seen in the injury site.
Conditioned medium from primary M1, but not M2, macrophages are able to induce astrocyte proliferation in both
organotypic spinal cord cultures and primary astrocytes. Soluble factors from M1 macrophages induce a reactive astrocyte
gene expression pattern, whereas M2 factors inhibit expression of these genes. M2-stimulated astrocytes are also able to
decrease both M1 and M2 macrophage proliferation and decrease TNFα production in M1 macrophages.
Conclusions: These results suggest a strong role of M1 macrophages in inducing reactive astrogliosis and the
existence of an astrocyte-mediated negative feedback system in order to dampen the immune response. These
results, combined with the poor outcomes of the current immunosuppressive steroid treatments in SCI, indicate
the need for more targeted therapies, taking into account the significantly different effects of M1 and M2
macrophages, in order to optimise outcome.
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Spinal cord injury (SCI) is one of the leading causes for
long-term disability in the Western world. Current treat-
ments are limited to early administration of steroids,
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cant functional improvement is still difficult to achieve.
The use of steroids illustrates the large role the
immune system plays in the pathology and resolution of
SCI. Following SCI, the initial phagocytotic response is
from the resident microglia, however, as the blood–brain
barrier is generally compromised following SCI, periph-
eral macrophages rapidly infiltrate the spinal cord and
become the predominant phagocytosing cell type at 3 days
post injury (dpi) [4] in mouse models. Additionally, the
infiltrating peripheral macrophages are responsible foricle distributed under the terms of the Creative Commons Attribution License
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acute phase of SCI [5]. Indeed, complete depletion of the
macrophage population following SCI led to functional
improvement in one study [6].
However, the picture may not be that simple, as macro-
phages are not a monolithic cell population. Macrophages
consist mainly of two subtypes, the pro-inflammatory M1
type and an anti-inflammatory/regenerative M2 type [7].
M2 macrophages have been implicated in tissue regener-
ation in muscle [8] and skin [9]. In an experimental
demyelination model in the brain, M2 type macrophages
were required for initiation of remyelination [10], and it has
been suggested that M2 macrophages are neurosupportive
in SCI as well [11]. This indicates a potential regenerative
role for these cells in the nervous system. There have been
several reports about the exact nature of the macrophage
response in SCI, with varying propor-tions of M1 and M2
having been described [11–15]. How these macrophage
phenotypical differences affect the development and reso-
lution of SCI is still unclear.
In the longer term following SCI, the formation of the
glial scar by reactive astrocytes is a crucial factor in the po-
tential long-term recovery of functionality. Although it has
recently been appreciated that at least some of the glial scar
may be derived from pericytes [16], at its heart, the glial
scar is comprised of a dense network of fibrous astrocytes,
filling in and surrounding the injury site. The presence of
large quantities of inhibitory extracellular proteoglycans in
the scar restricts the regrowth of endogenous axons into
the injury area [17]. Although traditionally viewed as detri-
mental to regeneration, the reactive astrocytes of the
glial scar may also have beneficial effects, including
aiding in the repair of the blood–brain barrier and
modulation of the immune cell response [18–20].
Although the glial scar is well studied, the initiation of
this astrocyte response is not well characterised. Factors
known to increase glial scar formation in the spinal cord
include TGFβ1 [21] and INFγ [1], amongst others. It has
also been suggested that Fgf2 may be used to decrease scar
formation and improve axonal permissibility [22], suggest-
ing growth factors are important in glial scar development.
In short, the complete picture of scar induction and
formation is far from clear. It is likely that the large-
scale immune cell infiltration plays in important role in
this. In this study, we aim to investigate the macro-
phage response to SCI and the interaction between
macrophages and astrocytes to elucidate the role these
play in the development of the glial scar. We report
that M1 macrophages, present in significant numbers
following SCI, are able to induce both astrocyte prolif-
eration and a reactive phenotype, which can be partially
counteracted by M2 macrophages. Additionally,
astrocytes previously stimulated by M2 macrophages
are able to decrease macrophage proliferation andactivity, indicating an important role of the astrocyte-
macrophage axis in SCI.
Materials and methods
Spinal cord impact model
All animal work was performed according to the proce-
dures in the Animals (Scientific Procedures) Act 1986
and local guidelines. Healthy female C57Bl/6 J mice of
18–20 g in weight were subjected to a spinal cord impact.
Under isofluorane anaesthesia, the dorsal skin was opened
and a laminectomy was performed at the T9 level. For
sham animals, at this point, the skin and muscle layers
were closed and the animals were allowed to recover. In
the impact group, animals were subjected to a controlled
spinal impact of 50 kDyn using the Infinite Horizon
Impactor device (Precision Scientific Instrumentation,
IH-0400). Following recovery of both groups, functional
impairment was assessed using the BBB scale [23]. Only
animals with a BBB score of <3 were considered in the
impact group and >18 in the sham group, with a mini-
mum of four animals per group.
Tissue harvesting and preparation
Seven days following SCI surgery, after the onset of glial
scar formation, animals were sacrificed using CO2 ex-
posure and transcardially perfused with PBS followed by
4 % PFA in PBS. Spinal cords were removed and post-
fixed in 4 % PFA in PBS overnight. They were then
transferred to 30 % sucrose for cryoprotection for 2 days,
before being mounted in OCT for sectioning in 15-μm
sections.
Immunohistochemistry
Sections were air-dried, postfixed in cold 1:1 acetone/
methanol for 2 min and blocked in 2 % BSA and 1 %
Triton X-100 in PBS for 1 h. Antibodies were applied
overnight at 4 °C and were: anti-CD68 (Abcam, ab53444,
1:100), anti-arginase-1 (Santa Cruz Biotechnology, sc-
18355, 1:50), anti-iNOS (BD Biosciences, 610329, 1:100)
and anti-GFAP (Cell Signaling, 12389S, 1:250). Controls
included species- and concentration-matched isotype
controls, which showed no staining (data not shown).
Antibodies were detected with the relevant secondary
antibodies conjugated to Alexa 488 or 594 (Life Technolo-
gies, 1:500), sections were mounted in DAPI containing
mounting medium and were imaged through Z-scanning
on an Applied Precision DeltaVision microscope.
Spinal cord organotypic cultures
Healthy C57BL/6 J mice of 6–12 weeks of age were
sacrificed through CO2 exposure and the spinal cord
removed. Meninges and other remaining tissue were
dissected off, and 500-μm sections of the thoracic and
abdominal cord were made using a McIlwain tissue
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(Corning, #354234) and cultured in DMEM/F12 medium
containing 20 % FBS, 1 % penicillin/streptomycin (P/S)
and 2 mM L-glutamine at 37 °C and 5 % CO2. For
immunohistochemistry and EdU detection, organotypic
cultures were fixed for 30 min in 4 % PFA in PBS,
cryoprotected in 30 % sucrose overnight and sectioned
in the same manner as the whole cords.Primary cell isolation and culture
Primary macrophages were cultured from bone marrow
progenitors. Bone marrow was isolated from femurs
by flushing the bone cavity with cold RPMI medium.
Marrow was pelleted by centrifugation and erythrocytes
were lysed using ammonium chloride lysing buffer (BD
Pharmlyse, 55899). Following two washes in cold RPMI
and straining through a 50-μm cell strainer, bone mar-
row progenitors were cultured in T75 flasks at 1 × 106/
ml in RPMI containing 10 % FBS, 2 mM L-glutamine
and 1 % P/S. For differentiation into M1 macrophages,
20 ng/ml GM-CSF was added, for M2 macrophages,
20 ng/ml of both M-CSF and Il-4 were added, all from
Peprotech, products 315-03A, 315-02B and 214-14A,
respectively. Following 7 days of culture, macrophages
were differentiated and ready for use.
Mouse primary astrocytes were isolated from neonatal
mixed glia cultures as previously described for rat [24].Conditioned medium production and use
Conditioned media were prepared from M1 and M2
macrophages, as well as from astrocytes that were non-
stimulated or stimulated with M1 or M2 macrophage
conditioned medium. In cultures that were previously
stimulated (with differentiation growth factors in the
case of macrophages and conditioned medium in the
case of astrocytes), cells underwent several medium
changes over 24 h following stimulation to ensure none
of the stimulating factors carried over into the condi-
tioned medium. For all cell types, conditioned medium
was prepared by incubating cells in their normal culture
medium for 3 days. Following conditioning, medium
was filtered through 0.22-μm syringe filters, aliquoted
and stored at −80 °C until use.
For all conditioned medium experiments, cultures or
organotypic cultures were simulated with 25 % condi-
tioned medium for macrophage medium or 50 % for
astrocyte medium, added to their usual culture medium.
For astrocyte experiments, controls consisted of incuba-
tion with a matched percentage unconditioned medium
of the same type as the conditioned medium. For macro-
phage experiments, controls consisted of conditioned
medium from unstimulated astrocytes. All experiments
were repeated using several batches of conditionedmedium, from cells from different isolations, to avoid
batch-specific effects.
MTT assays
Cells were seeded in 96-well plates at 5 × 104 cells/well,
at 4–6 wells per condition and allowed to adhere over-
night. The following day, the medium was changed to
experimental conditions, and the cells were allowed to
proliferate for 2, 4, or 6 days. MTT was then added to
cultures to a 0.5 mg/ml working concentration in the
medium from a 5-mg/ml stock solution in PBS. Follow-
ing 1–3 h of incubation, medium was removed, precipi-
tated dye was resuspended in DMSO and absorbance
was measured at 570 nm. Absorbance was quantified as
relative percentages compared to control conditions.
Organotypic slice cultures were incubated in experi-
mental conditions for 72 h with an n of 4 per condition,
before MTT was added at 0.5 mg/ml to the culture
medium. Following 2–4 h of exposure, slice cultures
were removed from the Matrigel into individual micro-
centrifuge tubes and dried under vacuum to obtain an
accurate dry tissue weight. Tissue was then resuspended
in 10 % SDS in H2O at 25 mg dry weight/ml and
dissolved at 60 °C under agitation for 6 h. Following cen-
trifugation to remove any non-dissolved tissue, absorb-
ance was measured at 570 nm. Absorbance was quantified
as relative percentages compared to control conditions.
Nucleotide incorporation assays and detection
Cells were seeded at 1 × 105 cells/well in poly-D-lysine
coated 8-well chamberslides and treated identical to those
used for MTT assays. Twenty-four hours prior to the end
of the protocol, 10-μM EdU was added from a 100-mM
1:10 DMSO/H2O stock. For organotypic cultures, EdU
was added 48 and 24 h prior to end of protocol. Cells
were then fixed for 20 min in 4 % PFA in PBS, and EdU
was detected as previously described [25]. Proliferation
was determined as percentage EdU incorporating cells of
total number of cells as determined by DAPI nuclear
staining. Organotypic cultures were sectioned prior to
detection of EdU. Proliferation was quantified as the
number of EdU incorporating cells per square millimetre
of section, with section area being determined in ImageJ.
This area measure corrected for varying sizes or organo-
typic cultures.
Quantitative PCR
RNA was extracted from unstimulated and M1- and
M2-stimulated astrocytes (n = 3) using the RNeasy kit
(Qiagen), according to manufacturer’s instructions. RNA
was then reverse transcribed using M-MLV (Promega,
M170A). Quantitative PCR for reactive astrocyte genes
GFAP, nestin, vimentin, cdk1, ccnb1, ccnd1, mki67, lcn2
and serpinA3, with gapdh as housekeeping, was performed
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mastermix (PrecisionPLUS-LR-SY), using a 60 °C anneal-
ing temperature. Primers used are listed in Additional file
1: Table S1. Data was analysed using the ΔΔCt method
and expressed as fold changes from control samples.
TNF production in macrophages and ELISA
M1 and M2 macrophages were stimulated with condi-
tioned medium from astrocytes previously stimulated by
M1- or M2-conditioned medium for 3 days. Following
stimulation, macrophages were replated into 24-well
plates at 2 × 105 cells/well, activated with 1 μg/ml of
β-glucan (Sigma Aldrich, C7821), and medium was
collected after 48 h. TNF levels were determined using
sandwich ELISA. Plates were coated with anti-TNF anti-
body (eBioscience, 14-7325-85, 1:500) overnight at 4 °C,
blocked with blocking buffer (eBioscience 00-4202-
55), and the samples were incubated overnight at 4 °C.Fig. 1 Macrophage response 7 days after contusive SCI. In sham surgical a
express the M1 marker iNOS (b, c), although there is iNOS expression in CD
(f–i). In contrast, following contusive injury, large number of macrophages
in both CD68+ and CD68− cells (j–m). As in the sham control, arginase is w
millimetre of section increased significantly in SCI compared to sham. s Qu
fraction of arginase-1+/CD68+ cells in both sham and impact groups, wheFollowing binding of biotinylated anti-TNF antibody (eBio-
science, 13-7326-85, 1:500) for 2 h at room tempe-
rature, streptavidin-HRP (eBioscience, 00-4106-93, 1:250)
was added for 45 min at room temperature, followed by
TMB substrate (eBioscience, 00-4201-56) for 20–30 min,
before being read on a spectrophotometer at 450 nm.
Statistical analysis
Groups were compared using one-way ANOVA with
Tukey post hoc testing in SPSS 20. Data is expressed as
average ± SEM.
Results
SCI induces a mixed M1/M2 macrophage response
Contusive injury was performed on mice to investigate
the nature of the macrophage response in our injury
model. BBB scores showed both successful sham and
impact groups (n = 4 for both), with scores of 18.6 ± 0.8nimals, low numbers of CD68+ cells are seen (a–i). These cells do not
68− cells. The M2 marker arginase-1 is widely expressed in CD68+ cells
is seen in the vicinity of the injury (j–q). iNOS expression is widespread,
idely expressed (n–q). r The total number of CD68+ cells per square
antification of macrophage subtypes following injury shows a constant
reas there is significant increase in number of iNOS+/CD68+ cells
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response was investigated by immunohistochemistry for
CD68 (pan-macrophage marker) and iNOS (M1 marker)
and arginase-1 (M2 marker). As shown in Fig. 1, spinal
cords from the sham group show very low numbers of
CD68+ cells, with some iNOS expression, though not in
the CD68+ cells. Arginase-1 expression is widespread, in-
cluding in CD68+ cells. Following contusive injury, large
numbers of CD68+ cells can be seen, with widespreadFig. 2 Effects of macrophage-derived soluble factors on spinal cord organo
following incubation with M1-conditioned, but not M2-conditioned mediu
M1, but not M2, macrophages show increased numbers of dividing cells, a
incorporating cells that also express GFAP is not changed in experimental
shows a significant fraction of dividing cells are GFAP+ astrocytesexpression of both iNOS and arginase-1 in CD68+ and
CD68− cells. When quantified (Fig. 1r), the large in-
crease in CD68+ cells following SCI is evident, 113 ±
19 vs 1324 ± 185 cells/mm2 (p = 0.002). Quantification
of marker expression on CD68+ cells (Fig. 1s) shows
that the percentage of CD68+ cells that express argi-
nase remains largely unchanged (52.8 ± 6.9 % vs 60.5 ±
5.3 %), while the percentage of iNOS expressing cells
is strongly increased (0 % vs 28.1 ± 2.8 %, p < 0.001).typic cultures. a Whole-slice MTT shows increased cellular respiration
m. b Cord cultures incubated for 72 h with conditioned medium of
s shown by EdU nucleotide incorporation. c The proportion of EdU
conditions. d–o Immunohistochemistry on cryosectioned slice cultures
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spinal cord organotypic cultures
To investigate the effects of soluble factors from macro-
phages on the spinal cord, organotypic spinal cord cul-
tures were incubated with M1 or M2 macrophage-
conditioned medium for 72 h. M1- but not M2-stimulated
cultures showed increased metabolic activity (p = 0.028),
in MTT assays (Fig. 2a, n = 4 per group). Furthermore, a
significantly higher (p = 0.016) density of EdU incorporat-
ing cells (Fig. 2b) was found in M1-stimulated cultures
(n = 3 per group), compared to control or M2. When the
identity of proliferating cells was investigated by combined
EdU incorporation and immunohistochemistry on sec-
tioned cultures, a significant fraction of EdU incorporating
cells in all conditions were found to express the astrocyte
marker GFAP (Fig. 2c–o), with percentages of 68 ± 8,
64 ± 9 and 69 ± 9 for control, M1 and M2, respectively.Primary astrocytes show a proliferative response to M1
macrophage soluble factors
In order to further confirm the proliferative effects of
M1 macrophage soluble factors, primary astrocytes were
used. Incubation of astrocytes with both M1 and M2
macrophage-conditioned medium for 2, 4 or 6 days
(n = 4) clearly shows a significant increase in the propor-
tion of EdU incorporating cells, with p = 0.005, p = 0.022
and p = 0.012 for days 2, 4 and 6, respectively (Fig. 3a, b).
This result was confirmed through MTT assays, withFig. 3 Effects of macrophage soluble factors on primary astrocytes. a Prima
medium show high levels of cell division as seen by EdU incorporation. b
percentage of cell division in M1- but not M2-stimulated cells at all time po
a proliferative effect of M1-, but not M2-, conditioned mediumagain significantly higher metabolic activity at days 2, 4
and 6, with p = 0.032, p = 0.009 and p < 0.001, respectively.
M1 and M2 macrophages have opposite effects on
astrocyte reactivity
The reactive marker expression of primary astrocytes was
investigated by qPCR for genes known to be strongly
upregulated in reactive astrocytes [26]. In primary mac-
rophages, all genes investigated, excluding serpinA3, were
significantly upregulated compared to control following
M1 stimulation, and five out of nine investigated genes
(nestin, vimentin, cdk1, mki67 and serpinA3) were signifi-
cantly downregulated following M2 stimulation (Fig. 4a).
In organotypic spinal cord cultures (Fig. 4b), gene expres-
sion is similar, with all genes except cdk1 and ccnb1 being
significantly upregulated following M1 stimulation and
all genes apart from ccnb1 being downregulated following
M2 stimulation.
Previously stimulated astrocytes can modulate
macrophage proliferation and TNFα production
In order to investigate whether any feedback exists from
astrocytes back to macrophages, a two-step experiment
was performed. Astrocytes were stimulated with M1 or
M2 macrophage-derived conditioned medium, after which
conditioned medium from these stimulated astrocytes was
collected, which was then added to fresh M1 or M2 mac-
rophages for EdU incorporation assays (Fig. 5b, c). Con-
ditioned medium from astrocytes previously stimulatedry astrocytes incubated with control or macrophage-conditioned
Quantification of number of EdU+ cells shows a significantly higher
ints. c MTT assays on macrophage-stimulated astrocytes again show
Fig. 4 M1 and M2 macrophage effects on astrocyte reactive expression pattern. a In primary astrocytes, qPCR for gene expression associated
with a reactive astrocyte phenotype shows opposite effects following stimulation with M1 or M2 macrophage-conditioned medium. Expression
of most genes is upregulated following M1 stimulation and downregulated following M2 stimulation. b In spinal cord organotypic cultures, very
similar gene expression changes are seen
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the mitotic index in both M1 (p = 0.017) and M2 mac-
rophages (p = 0.007). Again, this effect was confirmed
by MTT assays (n = 4, Fig. 5d), with a significant re-
duction in metabolism in both M1 (p < 0.001) and M2
(p = 0.009) macrophages. Apart from proliferation, β-
glucan-induced TNFα production by M1 macrophages
is also affected, with medium from previously M1-
stimulated astrocytes able to significantly (p < 0.001)
increase production, whereas M2-stimulated astrocyte
medium decreases production (p = 0.004). There was
no effect on M2 macrophages (data not shown).
Discussion
Given the current poor prognosis for functional recovery
following SCI, a thorough and full understanding of the
processes during that recovery period is crucial for
improving treatments. Here, we have studied the inter-
play between infiltrating macrophages and astrocytes. In
our study, we focused on a moderate contusive injury
and assessed macrophage response at the crucial time
point of the onset of glial scar formation. We observed amixed M1/M2 response, with a higher proportion of M2
macrophages. Although this seems to be in contradiction
with some reports suggesting the response is predomin-
antly M1, the ratio is most likely dependant on both the
severity and nature of the injury and the time point
investigated.
In accordance with our hypothesis that glial prolifera-
tion in the cord following injury may be driven by
macrophage infiltration, spinal cord organotypic cultures
exposed to conditioned medium from pro-inflammatory
M1 macrophages showed increased glial proliferation,
which was further confirmed though the use of primary
astrocytes. Apart from proliferation, soluble factors from
M1 also induce a reactive phenotype in both isolated
astrocytes and organotypic cultures, with M2 factors
having the opposite effect. This shows that M1 macro-
phages can promote both hallmarks of reactive astroglio-
sis, astrocyte proliferation and induction of specific gene
expression patterns. The exact mechanisms responsible
for this remain to be identified.
The fact that M2-stimulated astrocytes produce factors
that can significantly decrease proliferation of both M1
Fig. 5 Effects of soluble factors from previously stimulated astrocytes on primary macrophages. a Experimental set-up. Astrocytes were stimulated
with conditioned medium from M1 or M2 macrophages or left unstimulated. Following a wash, conditioned medium was then collected from
these and incubated with fresh primary macrophages. b, c EdU incorporation assays show medium from astrocytes previously stimulated with
M2-conditioned medium has an anti-proliferative effect on both M1 and M2 macrophages following 3 days of incubation. d The anti-proliferative
effect is confirmed using MTT assays. c As with M1 macrophages, the proliferation of M2 macrophages is also lower when incubated with
M2-stimulated astrocyte medium. e In M1 macrophages, TNFα release following β-glucan stimulation, as measured by ELISA, is also affected,
with significantly higher release following incubations with M1-stimulated astrocyte medium, and a significant decrease after incubation with
M2-stimulated astrocytes medium
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indicates the likely existence of a negative feedback loop
to control the inflammatory response following SCI.
Although the presence of M1 macrophages in the injury
site will drive reactive gliosis, the large numbers of M2
macrophages also present will counteract this effect,
both through decreasing astrocyte reactivity and through
decreasing macrophage proliferation via astrocytes. The
factor(s) mediating this feedback are as yet not known.
A link between astrocytes and immunosuppression in
SCI has been made before [18], and astrocytes may also
limit the neuroinflammation following cerebral stroke,
in a TGFβ1-dependent mechanism [27]. However, it
must also be noted that TGFβ1 has been implicated inpromoting glial scar formation [21], again indicating
the double-edged sword of the immune response. The
interactions between astrocytes and macrophages are
schematically summarised in Fig. 6.
Although this study strongly suggests that M1 macro-
phages play an important role in the development of
astrogliosis, the efficacy of immunosuppressive therapy
through steroid treatment in SCI has been under de-
bate. This illustrates the fine balance between the pro-
inflammatory and gliosis-inducing M1 macrophages and
the dampening role of the M2 macrophages and drives
home the need for more targeted therapies, aimed at
limiting the M1 response. Achieving this will likely be a
great help in SCI treatment, and, possibly in conjunction
Fig. 6 Schematic representation of astrocyte-macrophage
interactions. M1 macrophages produce factors that induce astrocyte
proliferation and reactive phenotype. These astrocytes are then able
to increase TNFα expression on M1 macrophages. M2 macrophages
produce factors that inhibit reactive astrocyte gene expression.
Stimulated astrocytes can reduce the proliferation of both M1 and
M2 macrophages and can dampen TNFα production in M1
macrophages
Haan et al. Journal of Neuroinflammation  (2015) 12:109 Page 9 of 10with one of the many cell transplantation strategies
currently under investigation, can hopefully lead to a
better functional outcome for patients.Additional file
Additional file 1: Table S1. Sequences and product sizes for reactive
astrocyte genes investigated by qPCR.
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